Ryzer Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-09-2024
- Paid Up Capital ₹ 5.00 M
as on 16-09-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue -89.71%
(FY 2022)
- Profit -810.93%
(FY 2022)
- Net Worth -10.43%
(FY 2022)
- Total Assets 15.92%
(FY 2022)
About Ryzer Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Payank Patel, Pramukhbhai Patel, Brijesh Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PTC104523
- Company No.
104523
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2018
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhinagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ryzer Pharmaceutical?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Payank Patel  | Director | 22-Nov-2023 | Current |
| Pramukhbhai Patel | Director | 05-Jan-2024 | Current |
| Brijesh Patel | Director | 05-Jan-2024 | Current |
| Ravikumar Patel | Director | 06-Feb-2024 | Current |
Financial Performance and Corporate Structure Insights of Ryzer Pharmaceutical.
Ryzer Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 89.71% decrease. The company also saw a substantial fall in profitability, with a 810.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ryzer Pharmaceutical?
In 2023, Ryzer Pharmaceutical had a public holding of 9.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ryzer Pharmaceutical?
Unlock and access historical data on people associated with Ryzer Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ryzer Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ryzer Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
